We are live on
!
Find out more
JCM
JS Capital Management Portfolio holdings
AUM
$109M
1-Year Est. Return
34.13%
This Fund
S&P 500
This Quarter
Est. Return
+31.19%
1 Year Est. Return
-34.13%
3 Year Est. Return
-16.34%
5 Year Est. Return
-37.7%
10 Year Est. Return
+464.39%
AUM
$1.32B
AUM Growth
+$529M
(+67%)
Cap. Flow
+$322M
Cap. Flow
% of AUM
24.31%
Top 10 Holdings %
Top 10 Hldgs %
74.86%
Holding
241
New
116
Increased
12
Reduced
13
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Herbalife
HLF
|
+$20.2M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$14.9M |
| 3 |
CTXS
Citrix Systems Inc
CTXS
|
+$12.8M |
| 4 |
Americold
COLD
|
+$12.6M |
| 5 |
Warner Music
WMG
|
+$9.36M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$45.9M |
| 2 |
10x Genomics
TXG
|
+$27.3M |
| 3 |
Microsoft
MSFT
|
+$24.9M |
| 4 |
Netflix
NFLX
|
+$22.6M |
| 5 |
Carvana
CVNA
|
+$19.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 25.87% |
| 2 | Technology | 15.53% |
| 3 | Communication Services | 8.66% |
| 4 | Healthcare | 8.35% |
| 5 | Real Estate | 2.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Regeneron Pharmaceuticals
REGN
$72.9B
| $374K | 0.03% |
+600
| New | +$341K |
|
102
Emergent Biosolutions
EBS
$379M
| $364K | 0.03% |
+4,600
| New | +$343K |
|
103
Toro Company
TTC
$8.79B
| $358K | 0.03% |
+5,400
| New | +$355K |
|
104
Salesforce
CRM
$154B
| $356K | 0.03% |
+1,900
| New | +$320K |
|
105
Cable One
CABO
$237M
| $355K | 0.03% |
+200
| New | +$358K |
|
|
APLT
106
DELISTED
Applied Therapeutics
APLT
| $351K | 0.03% |
+9,700
| New | +$406K |
|
107
Atmos Energy
ATO
$29.7B
| $349K | 0.03% |
+3,500
| New | +$353K |
|
108
Enerpac Tool Group
EPAC
$1.86B
| $347K | 0.03% |
19,700
+2,700
| +16% | +$45.6K |
|
109
Eli Lilly
LLY
$1.08T
| $345K | 0.03% |
+2,100
| New | +$322K |
|
110
Keysight
KEYS
$50.7B
| $343K | 0.03% |
+3,400
| New | +$334K |
|
111
Iovance Biotherapeutics
IOVA
$2.04B
| $335K | 0.03% |
+12,200
| New | +$401K |
|
112
Gogo Inc
GOGO
$525M
| $333K | 0.03% |
+105,500
| New | +$227K |
|
113
Amgen
AMGN
$209B
| $330K | 0.02% |
+1,400
| New | +$319K |
|
114
Beazer Homes USA
BZH
$888M
| $319K | 0.02% |
+31,700
| New | +$253K |
|
115
Fate Therapeutics
FATE
$275M
| $312K | 0.02% |
+9,100
| New | +$271K |
|
|
EIDX
116
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $310K | 0.02% |
+6,500
| New | +$302K |
|
117
FTI Consulting
FCN
$5.14B
| $309K | 0.02% |
+2,700
| New | +$327K |
|
118
Motorola Solutions
MSI
$72.1B
| $308K | 0.02% |
+2,200
| New | +$311K |
|
119
EPAM Systems
EPAM
$5.58B
| $302K | 0.02% |
+1,200
| New | +$264K |
|
|
DRNA
120
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $300K | 0.02% |
+11,800
| New | +$254K |
|
|
PFPT
121
DELISTED
Proofpoint, Inc.
PFPT
| $300K | 0.02% |
+2,700
| New | +$308K |
|
122
iHeartMedia
IHRT
$531M
| $295K | 0.02% |
+35,300
| New | +$275K |
|
123
Autodesk
ADSK
$51.8B
| $287K | 0.02% |
+1,200
| New | +$236K |
|
124
Haemonetics
HAE
$3.88B
| $278K | 0.02% |
+3,100
| New | +$313K |
|
125
Bally's
BALY
$708M
| $265K | 0.02% |
+11,900
| New | +$210K |
|
Similar funds
SC
WP
CFM
PL
PC
DHC
KWM
PCMN
JS Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, JS Capital Management held 241 positions worth $1.32B, up 67% from $795M the previous quarter. Its ten largest holdings account for 75% of the portfolio.
JS Capital Management deployed $322M of net new capital in Q2 2020, opening 116 new positions and adding to 12 existing holdings. Its largest new stake was Herbalife: 521,400 shares worth $23.5M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 26% of assets, down from 46% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Amazon, an estimated $45.9M trimmed.
- JS Capital Management's largest Q2 2020 buy was Herbalife: 521,400 shares worth $23.5M.
- JS Capital Management added most to Citrix Systems Inc in Q2 2020, an estimated $12.8M increase.
- JS Capital Management's biggest Q2 2020 reduction was Amazon, cutting an estimated $45.9M.
- JS Capital Management fully exited Alibaba in Q2 2020, selling an estimated $17.5M.
- JS Capital Management's ten largest holdings make up 75% of its $1.32B portfolio in Q2 2020.
- JS Capital Management opened 116 new positions and closed 98 in Q2 2020.
- JS Capital Management's portfolio value rose 67% quarter-over-quarter to $1.32B.
Based on JS Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.